Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (391-400 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|March 3, 2012
Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countriesB Chen, Y-Y Wang, Y Shen, et al.
Leukemia|March 3, 2012
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaS P Whitman, M A Caligiuri, K Maharry, et al.
Leukemia|March 8, 2012
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cellsY Yu, L Yang, M Zhao, et al.
Leukemia|March 20, 2012
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the diseaseC Royo, A Navarro, G Clot, et al.
Leukemia|October 22, 2011
Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disordersT Bochtler, M Kirsch, B Maier, et al.
Leukemia|September 5, 2008
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiationS Tavor, M Eisenbach, J Jacob-Hirsch, et al.
Leukemia|September 5, 2008
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesisE Terpos, E Kastritis, M Roussou, et al.
Leukemia|September 5, 2008
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndromeT Krejsgaard, L M Gjerdrum, E Ralfkiaer, et al.
Leukemia|September 19, 2008
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculationR Landolfi, L Di Gennaro, A Falanga
Pageof 1,398

Showing results (391-400 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|March 3, 2012
Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countriesB Chen, Y-Y Wang, Y Shen, et al.
Leukemia|March 3, 2012
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemiaS P Whitman, M A Caligiuri, K Maharry, et al.
Leukemia|March 8, 2012
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cellsY Yu, L Yang, M Zhao, et al.
Leukemia|March 20, 2012
Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the diseaseC Royo, A Navarro, G Clot, et al.
Leukemia|October 22, 2011
Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disordersT Bochtler, M Kirsch, B Maier, et al.
Leukemia|September 5, 2008
The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiationS Tavor, M Eisenbach, J Jacob-Hirsch, et al.
Leukemia|September 5, 2008
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesisE Terpos, E Kastritis, M Roussou, et al.
Leukemia|September 5, 2008
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndromeT Krejsgaard, L M Gjerdrum, E Ralfkiaer, et al.
Leukemia|September 19, 2008
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculationR Landolfi, L Di Gennaro, A Falanga
Pageof 1,398